|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/74 | |
| C07K 7/00 | |||
| C12Q 1/56 | |||
| A61K 38/43 |
| (11) | Patento numeris | 3062813 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14805360.6 |
| Europos patento paraiškos padavimo data | 2014-10-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2014/000056 |
| Data | 2014-10-21 |
| (87) | Numeris | WO 2015/063753 |
| Data | 2015-05-07 |
| (30) | Numeris | Data | Šalis |
| 22913413 | 2013-10-29 | IL | |
| 201361896674 P | 2013-10-29 | US |
| (72) |
ORR, Nadav, IL
PILPEL, Yair, IL
DORON, Sivan, IL
|
| (73) |
Omrix Biopharmaceuticals Ltd.,
Bldg.14 Weizmann Science Park P.O. Box 619, Rehovot 7610601,
IL
|
| (54) | COMPOUNDS AND METHODS FOR STABILIZING THROMBIN ACTIVITY |
| COMPOUNDS AND METHODS FOR STABILIZING THROMBIN ACTIVITY |